Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
British Journal of Haematology|August 4, 2020
Androgen derivatives improve blood counts and elongate telomere length in adult cryptic dyskeratosis congenitaMartin Kirschner, Margherita Vieri, Kim Kricheldorf, et al.
Annals of Hematology|October 4, 2023
Real-world analysis of ruxolitinib in myelofibrosis: interim results focusing on patients who were naïve to JAK inhibitor therapy treated within the JAKoMo non-interventional, phase IV trialSteffen Koschmieder, Susanne Isfort, Clemens Schulte, et al.
Clinical Immunology (Orlando, Fla.)|November 9, 2023
Telomere biology disorders may manifest as common variable immunodeficiency (CVID)Benjamin Rolles, Andres Caballero-Oteyza, Michele Proietti, et al.
European Journal of Haematology|July 7, 2025
Final Results From a Large, Non-Interventional, Phase 4 Study of Ruxolitinib for the Treatment of Myelofibrosis in Clinical RoutineSteffen Koschmieder, Susanne Isfort, Clemens Schulte, et al.
Annals of Hematology|July 5, 2024
FRACTION: protocol of a phase II study of Fedratinib and Nivolumab combination in patients with myelofibrosis and resistance or suboptimal response to JAK-inhibitor treatment of the German MPN study group (GSG-MPN)Susanne Isfort, Nikolas von Bubnoff, Haifa Kathrin Al-Ali, et al.
Annals of Hematology|May 23, 2026
Value of functional iron parameters in diagnostic re-assessment of MPN: refinement of iron-deficiency markers by zinc protoporphyrin (ZPP)Kirsi Manz, Myriam Kobrosly, Carl C Crodel, et al.
Annals of the New York Academy of Sciences|October 25, 2019
Comparison of flow-FISH and MM-qPCR telomere length assessment techniques for the screening of telomeropathiesMonica S Ventura Ferreira, Martin Kirschner, Insa Halfmeyer, et al.
Haematologica|August 29, 2015
Outcome of advanced chronic lymphocytic leukemia following different first-line and relapse therapies: a meta-analysis of five prospective trials by the German CLL Study Group (GCLLSG)Paula Cramer, Susanne Isfort, Jasmin Bahlo, et al.
Cancers|August 27, 2021
The Unfolded Protein Response Is a Major Driver of LCN2 Expression in BCR-ABL- and JAK2V617F-Positive MPNStefan Tillmann, Kathrin Olschok, Sarah K Schröder, et al.
Leukemia|July 12, 2020
Correction: Frequency of infections in 948 MPN patients: a prospective multicenter patient-reported pilot studyCarl C Crodel, Kathleen Jentsch-Ullrich, Steffen Koschmieder, et al.
Pageof 5